Published in Cancer Res on May 15, 1989
Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer (2009) 5.06
Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci U S A (1994) 1.84
Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis. Proc Natl Acad Sci U S A (1998) 1.76
Topoisomerase assays. Curr Protoc Pharmacol (2012) 0.99
JNK inhibitor SP600125 promotes the formation of polymerized tubulin, leading to G2/M phase arrest, endoreduplication, and delayed apoptosis. Exp Mol Med (2009) 0.87
Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. Environ Health Perspect (1996) 0.86
Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro. Mol Cell Biol (1992) 0.84
DNA topoisomerases participate in fragility of the oncogene RET. PLoS One (2013) 0.79
Ellipticine increases the superhelical density of intracellular SV40 DNA by intercalation. Nucleic Acids Res (1992) 0.76
Use of a rapid throughput in vivo screen to investigate inhibitors of eukaryotic topoisomerase II enzymes. Antimicrob Agents Chemother (1998) 0.76
DNA-protein interaction dynamics at the Lamin B2 replication origin. Cell Cycle (2015) 0.75
Characterization of a novel anti-cancer compound for astrocytomas. PLoS One (2014) 0.75
Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells. Cancer Chemother Pharmacol (1994) 0.75
Cleavage of DNA with methidiumpropyl-EDTA-iron(II): reaction conditions and product analyses. Biochemistry (1984) 4.20
Map of distamycin, netropsin, and actinomycin binding sites on heterogeneous DNA: DNA cleavage-inhibition patterns with methidiumpropyl-EDTA.Fe(II). Proc Natl Acad Sci U S A (1982) 3.81
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol (1992) 3.42
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene (1999) 3.23
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med (1983) 2.63
Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol (1993) 2.40
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32
Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry (1989) 2.26
Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ (1991) 2.20
Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. J Biol Chem (1994) 2.04
Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mol Cell Biol (1991) 2.03
Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem (2000) 2.00
Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol Pharmacol (1988) 1.95
In-person vs telephone-administered multiple-pass 24-hour recalls in women: validation with doubly labeled water. J Am Diet Assoc (2000) 1.93
Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res (1979) 1.93
A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science (1998) 1.86
Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole. Cancer Res (1980) 1.78
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. Cancer Res (1994) 1.75
Cleavage of chromatin with methidiumpropyl-EDTA . iron(II). Proc Natl Acad Sci U S A (1983) 1.71
Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme. J Biol Chem (1987) 1.66
Longitudinal changes in fatness in white children: no effect of childhood energy expenditure. Am J Clin Nutr (1998) 1.64
Influence of body composition on the accuracy of reported energy intake in children. Obes Res (2000) 1.59
Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci U S A (1989) 1.58
Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J Med Chem (1989) 1.57
Synthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues. J Med Chem (1989) 1.43
Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer (1977) 1.39
Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res (1992) 1.39
Diaminobenzidine as a myelin stain in semithin plastic sections. Biotech Histochem (1999) 1.38
Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep (1978) 1.31
Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg Med Chem (1997) 1.31
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Cross-finger pedicle flaps in the hand. J Bone Joint Surg Am (1971) 1.29
Developmental changes in energy expenditure and physical activity in children: evidence for a decline in physical activity in girls before puberty. Pediatrics (1998) 1.28
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J Med Chem (1991) 1.28
Dependence of mammalian DNA replication on DNA supercoiling. II. Effects of novobiocin on DNA synthesis in Chinese hamster ovary cells. Biochim Biophys Acta (1979) 1.27
Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia. Biochem Pharmacol (1978) 1.26
Identification of quantitative trait loci affecting reproduction in pigs. J Anim Sci (2001) 1.24
Anatomical course of the thenar branch of the median nerve--usually in a separate tunnel through the transverse carpal ligament. J Bone Joint Surg Am (1970) 1.19
Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors. J Natl Cancer Inst (1989) 1.19
Plakortides, novel cyclic peroxides from the sponge Plakortis halichondrioides: activators of cardiac SR-CA(2+)-pumping ATPase. J Nat Prod (1996) 1.17
Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro. J Natl Cancer Inst (1992) 1.16
Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase. Cancer Res (1976) 1.16
In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat Rep (1978) 1.15
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. Cancer Res (1988) 1.13
DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs. Biochemistry (1986) 1.12
Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res (1987) 1.09
The pronator quadratus in motions and in stabilization of the radius and ulna at the distal radioulnar joint. J Hand Surg Am (1976) 1.08
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Cancer Res (1985) 1.07
Fat intake and adiposity in children of lean and obese parents. Am J Clin Nutr (1996) 1.06
Biological responses to porcine respiratory and reproductive syndrome virus in pigs of two genetic populations. J Anim Sci (2005) 1.05
Exposure of mice to topical bovine thrombin induces systemic autoimmunity. Am J Pathol (2001) 1.05
Differential immunity in pigs with high and low responses to porcine reproductive and respiratory syndrome virus infection. J Anim Sci (2007) 1.04
Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. Proc Natl Acad Sci U S A (1987) 1.03
Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs. Gene (1994) 1.03
Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content. Mol Pharmacol (1990) 1.03
Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II. Cancer Res (1990) 1.02
Selective excision of gamma ray damaged thymine from the DNA of cultured mammalian cells. Biochim Biophys Acta (1975) 1.02
Estimation of genetic parameters for average daily gain using models with competition effects. J Anim Sci (2008) 1.01
Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem (1996) 1.01
In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells. Oncol Res (1993) 1.01
Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content. Oncol Res (1992) 1.00
Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Int J Immunopharmacol (1994) 0.99
Experimental antitumor activity of aminoanthraquinones. Cancer Treat Rep (1979) 0.99
Use of COMPARE analysis to discover new natural product drugs: isolation of camptothecin and 9-methoxycamptothecin from a new source. J Nat Prod (2000) 0.99
Synthesis and structure-activity relationships of cytotoxic 7-hydroxy sterols. J Nat Prod (1994) 0.99
Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res (1986) 0.99
Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds. J Med Chem (1987) 0.99
Cytotoxicity and antitumor activity of some tetrahedral bis(diphosphino)gold(I) chelates. J Med Chem (1990) 0.99
Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast. Mol Pharmacol (1991) 0.98